Status:
COMPLETED
Aides in Respiration Health Coaching for COPD
Lead Sponsor:
University of California, San Francisco
Collaborating Sponsors:
Patient-Centered Outcomes Research Institute
Conditions:
Chronic Obstructive Pulmonary Disease (COPD)
Eligibility:
All Genders
40-95 years
Phase:
NA
Brief Summary
This study examined whether health coaches can improve the management of chronic obstructive pulmonary disease (COPD) in a population of vulnerable patients cared for in 'safety-net' clinics. The stud...
Detailed Description
Health coaching is a promising model for improving evidence-based care for patients with COPD which had not been evaluated at the time the current study began in 2014. Health coaching by health worker...
Eligibility Criteria
Inclusion
- Patient at one of the participating primary care clinics (at least 1 visit in past 12 months)
- Age 40 and older
- Speaking English or Spanish
- Plan to continue to be seen at current clinic and to not leave the area for \>2 months anytime in the next 9 months or to be absent at 9 or 15 months
- COPD defined as ever having had a post-bronchodilator Forced Expiratory Volume in 1 second/Forced Vital Capacity (FEV1/FVC) \<.70 of FEV1/FVC of .70 to .74 and diagnosis of COPD by the study pulmonologist
- Willingness to attempt spirometry
- At least moderate COPD, defined as at least one of the following:
- Ever Forced Expiratory Volume in 1 second (FEV1) \< 80% predicted
- 1 or more emergency department (ED) visit for COPD exacerbation in past 12 months
- 1 or more hospital stays for COPD exacerbation in past 12 months
- 1 or more prescriptions for oral prednisone for a COPD exacerbation in past 12 months
- Ever on home oxygen therapy
- Ever outpatient percutaneous oxygen saturation of \</=88%
- Ever outpatient partial pressure of oxygen (ppO2) by arterial blood gas (ABG) of \</=55mm Hg
- At least 3 outpatient visits for COPD in past 12 months AND (a current COPD Assessment Test (CAT) score of \>/=10 OR an modified Medical Research Council (mMRC) score of \>/=2).
- Currently using tiotropium inhaler or combination inhaled corticosteroid and long-acting beta agonist
Exclusion
- Unable to participate in the study due to mental or physical impairment
- Severe or terminal illness that precludes focus on COPD
- No phone
Key Trial Info
Start Date :
November 12 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 4 2017
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT02234284
Start Date
November 12 2014
End Date
May 4 2017
Last Update
June 10 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
San Francisco Departmen of Public Health Community Clinics
San Francisco, California, United States, 94110